Astellas Pharma acquires Iveric Bio for $5.9 billion



Japanese giant Astellas Pharma Inc. announced on Monday it has reached an agreement to acquire the entire stake of American biopharma company Iveric Bio for $5.9 billion or $40 per share in cash.

The…